The research study on the “Single-use Bioprocessing Market – Global Outlook & Forecast 2023-2028”, recently published by Arizton Advisory & Intelligence, states that the global single-use bioprocessing market to reach USD 26.54 billion by 2028.
Single-Use Bioprocessing Market Report Scope
| Report Attributes | Details |
| Market Size (2028) | USD 26.54 Billion |
| Market Size (2022) | USD 9 Billion |
| CAGR (2022-2028) | 19.74% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segmentation | Product Type, Application, End-users, Method, Workflow, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Market Dynamics |
|
The report provides an in-depth analysis of the present scenario of the global single-use bioprocessing market and its market dynamics from 2023 to 2028. It comprehensively overviews various factors that drive market growth, restraints, and trends. Both the demand and supply aspects of the industry are thoroughly examined. Furthermore, the report includes profiles and evaluations of major companies and several other prominent players operating within the sector.
To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3887
The global single-use bioprocessing market has grown significantly in the upcoming years. New product launches enabling single-use technology adoption are a great way to reduce waste and improve sustainability. Single-use technology allows companies to reduce their reliance on disposable products and materials while still providing customers with quality products. This technology can be used to create more efficient and sustainable packaging and products that are easier to use and more cost-effective. In addition, single-use technology can help reduce the environmental impact of production and consumption and the amount of waste generated. With the launch of new products that enable the adoption of single-use technology, companies can positively impact the environment and create a more sustainable future.
Segmentation Insights
Product Type: Single-use bioprocessing equipment is a technology that has revolutionized the biopharmaceutical industry. This technology has increased efficiency, flexibility, safety, and cost savings during bioprocessing. Single-use bioprocessing equipment is a system of technologies designed to replace reusable stainless steel and other materials traditionally used in bioprocessing. This equipment uses single-use components, including bags, bioreactors, tubing, syringes, connectors, and filters, disposed of after use. In 2022, the single-use bioprocessing equipment product type held a larger share of the global single-use bioprocessing market.
Application: the global single-use bioprocessing market by application is segmented as monoclonal antibodies (mABs), vaccines, cell therapies, and others. Monoclonal antibodies (mABs) hold the largest industry share by application segment. Single-use bioprocessing is an emerging technology in the biopharmaceutical industry that has revolutionized how monoclonal antibodies (mAbs) are produced. Single-use bioprocessing involves using disposable bioreactors and other components to produce proteins, such as mAbs. Unlike traditional stainless-steel bioreactors, single-use bioreactors can be quickly set up, require minimal cleaning, and reduce the risk of cross-contamination. Due to their complexity and high cost, these advantages make single use bioprocessing particularly attractive for mAb production.
End-User: the biopharmaceutical manufacturers segment accounted for over 39% of the global single-use bioprocessing market. This segment dominates the overall market and will likely retain its dominance in the coming years due to its widespread adoption in research and commercial manufacturing applications. Several biopharmaceutical manufacturers have already explored SUB solutions usage in commercial manufacturing. However, their potential benefits are significant, particularly in small-volume manufacturing in modular facilities. Most biopharmaceutical manufacturers, especially large and medium-sized companies, spend over $50 million on equipment annually. It has been witnessed that a high percentage of capital is being spent on single-use bioprocessing by biopharmaceutical manufacturers.
Method: the global single-use bioprocessing market by the method is categorized as filtration, storage & transport, cell culture, mixing, and purification. Filtration holds the largest share of the market. Single-use bioprocessing is a method of filtration that has grown increasingly popular in the biotechnology industry. It involves using disposable, self-contained systems to prepare, filter, and process bioproducts. This form of filtration has many advantages, especially for pharmaceutical and biological product manufacturing. Single-use bioprocessing has revolutionized the biotechnology industry. This reduces the need for traditional equipment and infrastructure, resulting in cost savings and improved production efficiency.
Workflow: the upstream workflow segment dominated the global single-use bioprocessing market. Upstream single-use bioprocessing workflow is focused on upstream unit operations such as cell culture, protein expression, and harvest. Over the last decade, advances in this workflow have enabled biopharmaceutical companies to streamline the process, increase product yields, and reduce costs. The upstream single-use bioprocessing workflow advancements have provided biopharmaceutical companies with a more efficient and cost-effective workflow.
Buy the Report Now: https://www.arizton.com/market-reports/single-use-bioprocessing-market
Post-Purchase Benefit
- 1hr of free analyst discussion
- 10% of customization
Growing Investment Activities Supporting Single-use Technology in Biomanufacturing
- In 2021, Merck announced European expansion plans for single-use products critical to manufacturing vaccines and lifesaving therapies. The company’s $27 million investment has enhanced its European expansion plans for this key technology, which produces COVID-19 vaccines and other lifesaving therapies. Molsheim is the first site in Europe where Merck manufactured the product. Further production sites are in Danvers, Massachusetts, US, and Wuxi, China.
- In 2022, Merck KGaA signed an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to significantly expand the first APAC Mobius Single-Use manufacturing center in China. The company planned to invest approximately $110 million over six years by expanding the existing Wuxi production site to increase biopharma single-use assemblies and custom design capabilities significantly.
- In March 2022, ABEC, a global provider of engineered solutions and services for biotech manufacturing, announced the completion of an expansion of its Fermoy, Ireland, cleanroom for single-use disposable container (DC) manufacturing. The expansion is fully operational and is pivotal for the biopharmaceutical industry, as many customers cite lead times of a year or more from other suppliers.
- In August 2022, ABEC announced an investment of $11 million to expand single-use disposable container (DC) manufacturing capacity for its CSR biomanufacturing solutions. The company’s project in Wilson includes a 50,000-square-foot facility on 13 acres, outfitted with an ISO-7 cleanroom and state-of-the-art manufacturing equipment. The new facility is ABEC’s third global DC manufacturing site and has been fully operational since Q2 2023.
Key Company Profiles
- Thermo Fisher Scientific
- Sartorius Stedim Biotech
- Danaher
- Merck KGaA
- Avantor
- 3i Group
- 3M
- ABEC
- Adolf Kühner
- AdvantaPure
- Barry-Wehmiller Companies
- Broadley-James
- Celltainer Biotech
- CerCell A/S
- CESCO Bioengineering
- Charter Medical
- Colder Products Company
- Corning
- Distek
- DrM, Dr. Mueller
- Emerson Electric
- Entegris
- Eppendorf
- Foxx Life Sciences
- Getinge
- HIGH PURITY NEW ENGLAND
- Holland Applied Technologies
- Lonza
- MEISSNER FILTRATION PRODUCTS
- New Horizon Biotech
- OmniBRx Biotechnologies
- PARKER HANNIFIN
- PendoTECH
- PBS Biotech
- Repligen
- Saint-Gobain
- Sentinel Process Systems
- Solaris Biotechnology
- SYSBIOTECH GmbH
- Watson-Marlow Fluid Technology Solutions
- Weigao Group
- W.L. Gore & Associates
Market Segmentation
- Product Type: Single-use Bioprocessing Equipment and Simple & Peripheral Devices
- Application: Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, and Others
- End-users: Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), and R&D Companies & Research Institutes
- Method: Filtration, Storage & Transport, Cell Culture, Mixing, and Purification
- Workflow: Upstream and Downstream
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Check the detailed table of contents of the report @ https://www.arizton.com/market-reports/single-use-bioprocessing-market?details=tableOfContents
Key Questions Answered in the Report:
- How big is the global single-use bioprocessing market?
- What is the growth rate of the single-use bioprocessing market?
- What are the rising trends in the single-use bioprocessing market?
- Which region holds the most significant global single-use bioprocessing market share?
- Who are the key players in the global single-use bioprocessing market?
Why Arizton Research Reports?
- 100% Customer Satisfaction
- 24×7 availability – we are always there when you need us.
- 200+ Fortune 500 Companies trust Arizton’s report.
- 80% of our reports are exclusive and first in the industry.
- 100% more data and analysis.
- 1500+ reports published to date.
Explore more healthcare reports: https://www.arizton.com/market-reports/category/healthcare-lifesciences
Check Out Some of the Top-Selling Research Reports:
Biopharmaceutical Contract Manufacturing Market – Global Outlook & Forecast 2022-2027
https://www.arizton.com/market-reports/biopharmaceutical-contract-manufacturing-market
Single-Use Bioprocessing Probes And Sensors Market – Global Outlook & Forecast 2022-2027
https://www.arizton.com/market-reports/single-use-bioprocessing-probes-and-sensors-market
Vaccine Contract Manufacturing Market – Global Outlook and Forecast 2021-2026
https://www.arizton.com/market-reports/vaccine-contract-manufacturing-market
Surgical Wound Closure Devices Market – Global Outlook and Forecast 2021-2026
https://www.arizton.com/market-reports/surgical-wound-closure-devices-market-size-analysis
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Contact Us:
Call: +1-312-235-2040
+1 302 469 0707
Mail: enquiry@arizton.com
Contact Us: https://www.arizton.com/contact-us
Blog: https://www.arizton.com/blog
Website: https://www.arizton.com/